Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugimoto, H.
Right arrow Articles by Makino, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugimoto, H.
Right arrow Articles by Makino, H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 12 2075-2081, Copyright © 1997 by American Diabetes Association


ARTICLES

Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation

H Sugimoto, K Shikata, K Hirata, K Akiyama, M Matsuda, M Kushiro, Y Shikata, N Miyatake, M Miyasaka and H Makino
Department of Medicine III, Okayama University Medical School, Japan.

Mononuclear cells, including monocytes/macrophages and T-cells, are considered to be involved in the progression of diabetic nephropathy, although the mechanism of their recruitment into diabetic glomeruli is unclear. The intercellular adhesion molecule-1 (ICAM-1) promotes the infiltration of leukocytes into atherosclerotic lesions as well as inflammatory tissues. In the present study, we investigated the expression of ICAM-1 in the glomeruli of streptozotocin-induced diabetic rats. The expression of ICAM-1 was increased significantly during the early stage of diabetes. The number of mononuclear cells, primarily monocytes/macrophages and lymphocytes, was significantly increased in diabetic glomeruli. Mononuclear cell infiltration into diabetic glomeruli was prevented by anti-ICAM-1 monoclonal antibody. Insulin treatment decreased ICAM-1 expression and mononuclear cell infiltration. The ICAM-1 expression on cultured human umbilical vein endothelial cells was not induced under high glucose culture conditions. Glomerular hyperfiltration is a characteristic change in the early stage of diabetic nephropathy. Treatment with aldose reductase inhibitor, which prevented glomerular hyperfiltration without changes in blood glucose levels, decreased ICAM-1 expression and mononuclear cell infiltration. Moreover, we examined the ICAM-1 expression in the glomeruli of the 5/6 nephrectomized rat, which is a model for glomerular hyperfiltration without hyperglycemia. The ICAM-1 expression and infiltration of mononuclear cells was significantly increased in the glomeruli of 5/6 nephrectomized rats. We conclude that ICAM-1 is upregulated and promotes the recruitment of mononuclear cells in diabetic glomeruli. Moreover, glomerular hyperfiltration that occurs in the early stage of diabetic glomeruli may be one of the potential mechanisms of ICAM-1 upregulation in diabetic nephropathy.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Ohga, K. Shikata, K. Yozai, S. Okada, D. Ogawa, H. Usui, J. Wada, Y. Shikata, and H. Makino
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-{kappa}B activation
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1141 - F1150.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. K. Usui, K. Shikata, M. Sasaki, S. Okada, M. Matsuda, Y. Shikata, D. Ogawa, Y. Kido, R. Nagase, K. Yozai, et al.
Macrophage Scavenger Receptor-A-Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation
Diabetes, February 1, 2007; 56(2): 363 - 372.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Giunti, D. Barit, and M. E. Cooper
Mechanisms of Diabetic Nephropathy: Role of Hypertension
Hypertension, October 1, 2006; 48(4): 519 - 526.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Galkina and K. Ley
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 368 - 377.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Nakamura, K. Shikata, M. Hiramatsu, T. Nakatou, T. Kitamura, J. Wada, T. Itoshima, and H. Makino
Serum Interleukin-18 Levels Are Associated With Nephropathy and Atherosclerosis in Japanese Patients With Type 2 Diabetes
Diabetes Care, December 1, 2005; 28(12): 2890 - 2895.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Yozai, K. Shikata, M. Sasaki, A. Tone, S. Ohga, H. Usui, S. Okada, J. Wada, R. Nagase, D. Ogawa, et al.
Methotrexate Prevents Renal Injury in Experimental Diabetic Rats via Anti-Inflammatory Actions
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3326 - 3338.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Y. Kikuchi, T. Imakiire, M. Yamada, T. Saigusa, T. Hyodo, N. Hyodo, S. Suzuki, and S. Miura
Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats
Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1573 - 1581.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. F. Navarro, C. Mora, M. Muros, and J. Garcia
Additive Antiproteinuric Effect of Pentoxifylline in Patients with Type 2 Diabetes under Angiotensin II Receptor Blockade: A Short-Term, Randomized, Controlled Trial
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2119 - 2126.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Y. Chow, D. J. Nikolic-Paterson, E. Ozols, R. C. Atkins, and G. H. Tesch
Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1711 - 1722.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, and S. K. Srivastava
Activation of Nulcear Factor-{kappa}B by Hyperglycemia in Vascular Smooth Muscle Cells Is Regulated by Aldose Reductase
Diabetes, November 1, 2004; 53(11): 2910 - 2920.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Okada, K. Shikata, M. Matsuda, D. Ogawa, H. Usui, Y. Kido, R. Nagase, J. Wada, Y. Shikata, and H. Makino
Intercellular Adhesion Molecule-1-Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes
Diabetes, October 1, 2003; 52(10): 2586 - 2593.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. Usui, K. Shikata, M. Matsuda, S. Okada, D. Ogawa, T. Yamashita, K. Hida, M. Satoh, J. Wada, and H. Makino
HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats
Nephrol. Dial. Transplant., February 1, 2003; 18(2): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. K. Fujihara, A. L. Mattar, J. M. Vieira Jr, D. M. A. C. Malheiros, I. d. L. Noronha, A. R. R. Goncalves, G. de Nucci, and R. Zatz
Evidence for the Existence of Two Distinct Functions for the Inducible NO Synthase in the Rat Kidney: Effect of Aminoguanidine in Rats with 5/6 Ablation
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2278 - 2287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. L. Riser, J. Varani, P. Cortes, J. Yee, M. Dame, and A. K. Sharba
Cyclic Stretching of Mesangial Cells Up-Regulates Intercellular Adhesion Molecule-1 and Leukocyte Adherence : A Possible New Mechanism for Glomerulosclerosis
Am. J. Pathol., January 1, 2001; 158(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. K. Fujihara, D. M. Avancini Costa Malheiros, I. de Lourdes Noronha, G. De Nucci, and R. Zatz
Mycophenolate Mofetil Reduces Renal Injury in the Chronic Nitric Oxide Synthase Inhibition Model
Hypertension, January 1, 2001; 37(1): 170 - 175.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Jilma, S. Dallinger, N. Hergovich, H.-G. Eichler, V. Richter, and O. F. Wagner
Effects of Hyperinsulinemia on Plasma Levels of Circulating Adhesion Molecules
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1748 - 1751.
[Abstract] [Full Text]


Home page
Nephrol Dial TransplantHome page
J. Wada, K. Shikata, and H. Makino
Novel approaches to unravel the genesis of glomerulosclerosis by new methodologies in molecular biology and molecular genetics
Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2551 - 2553.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.